About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tecrtm1.1Migar
targeted mutation 1.1, Michihiro Igarashi
MGI:7868156
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Tecrtm1.1Migar/Tecrtm1.1Migar B6N.Cg-Tecrtm1.1Migar MGI:8204683
ht2
Tecrtm1.1Migar/Tecr+ B6N.Cg-Tecrtm1.1Migar MGI:8204688


Genotype
MGI:8204683
hm1
Allelic
Composition
Tecrtm1.1Migar/Tecrtm1.1Migar
Genetic
Background
B6N.Cg-Tecrtm1.1Migar
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tecrtm1.1Migar mutation (0 available); any Tecr mutation (27 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• no homozygotes are observed at E11.5-E13.5 or at P1; viable homozygotes are last recovered in Mendelian ratios at E9.5-E10.0

embryo
• at E9.5, somite number is 24 versus 30 in wild-type embryos
• homozygous embryos exhibit a substantially regressed amnion by E11.5

nervous system
• at E9.5, nervous system development is delayed with severe inhibition of axon and network formation
• at E9.5, axonal projections of the petrosal ganglion and dorsal root ganglion (DRG) are significantly reduced
• axonal projections from the cranial nerve and dorsal root ganglia (DRG) ganglia are delayed
• neuronal development is severely inhibited in both the CNS and PNS
• at E9.5, the midbrain remains immature and displays retarded extension
• at E9.5, neural projections from the ventral neurons located in the diencephalon and mesencephalon are significantly decreased in number
• trigeminal ganglia projections toward the cerebellar primordium and the ascending components of the trigeminal ganglia-derived fibers display impaired formation
• at E9.5, the cranial nerves remain immature and display retarded extension
• no hypoglossal nerve (XII cranial nerve) is found

homeostasis/metabolism
• both free and bound very-long-chain fatty acids (VLCFAs) are decreased
• free FAs involved in C24:1 and C24:2 synthesis are significantly decreased
• VLCFA-containing ceramide is reduced; ceramide-C24 and ceramide with >C24 FAs are significantly decreased in a VLCFA-dependent manner
• hexosylceramide (a type of glycosphingolipid) with C26 or longer FA chains is reduced independent of VLCFAs
• at E9.5, dihydroceramide synthesis is inhibited in a fatty acid (FA) chain length-dependent manner
• sphingolipids downstream of ceramide show a marked reduction in FAs with acyl chains of C20 or longer; the amount of C24 FAs is largely decreased
• amount of dihydrosphingosine, an upstream product of ceramide, is highly increased
• in contrast, changes in the amount of glycerophospholipids are not dependent upon FA chains

cellular
• at E9.5, axonal projections of the petrosal ganglion and dorsal root ganglion (DRG) are significantly reduced
• axonal projections from the cranial nerve and dorsal root ganglia (DRG) ganglia are delayed
• neuronal development is severely inhibited in both the CNS and PNS




Genotype
MGI:8204688
ht2
Allelic
Composition
Tecrtm1.1Migar/Tecr+
Genetic
Background
B6N.Cg-Tecrtm1.1Migar
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tecrtm1.1Migar mutation (0 available); any Tecr mutation (27 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• axonal growth of dorsal root ganglia (DRG) is impeded
• severe defects in neuronal development are due to impaired neuronal polarity determination
• cultured E14.5 hippocampal neurons exhibit a multipolar form characterized by multiple, shorter axons and absence of Pard3 (par-3 family cell polarity regulator, aka Par3) accumulation in the axon growth cone, indicating impaired neuronal polarity
• neurons show a lack of lipid rafts in the growth cone, as indicated by a significant decrease in the lipid-ordered (Lo)-phase area (marking lipid-raft domains) and reduced expression of neuronal lipid raft markers (e.g. GPM6a and GM1 ganglioside)
• GPSN2 overexpression in the growth cone rescues the % of polarized hippocampal neurons with a single axon and restores axon length to wild-type values
• application of VLCFA-ceramide (C24:0 ceramide), but not C16:0 ceramide or C24:0 phosphatidylcholine, to heterozygous neurons rescues both neuronal polarity determination and lipid-raft density in the growth cone
• hypoglossal nerve (XII cranial nerve) is shorter than in wild-type embryos

homeostasis/metabolism
• free FAs involved in C24:1 and C24:2 synthesis are significantly decreased
• ceramide-C24 and ceramide with >C24 FAs are significantly decreased in a VLCFA-dependent manner
• hexosylceramide (a type of glycosphingolipid) with C26 or longer FA chains is reduced independent of VLCFAs
• major ganglioside species (GD3, GM1, and GM3) are significantly decreased in the growth cone membrane (GCM) of neurons from E16 brains but not in the whole-cell membrane (WCM, i.e. entire neuronal membrane)
• various GCM gangliosides are decreased, and this change is mirrored by relative increases in WCM for many ganglioside species
• at E9.5, sphingolipids downstream of ceramide show a marked reduction in fatty acids (FAs) with acyl chains of C20 or longer; the amount of C24 FAs is largely decreased

cellular
• axonal growth of dorsal root ganglia (DRG) is impeded
• severe defects in neuronal development are due to impaired neuronal polarity determination





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/25/2025
MGI 6.24
The Jackson Laboratory